Market Research Logo

Diabetes Market Research Reports & Industry Analysis

The markets for diabetes care products can be segmented as either monitoring/testing products or therapeutics products. Testing products can be further segmented by analyte for glucose, ketones, and microalbumin/albumin. Therapeutic products can also be further segmented as insulin, oral hypoglycemic agents and drugs to treat diabetic complications. Drugs to treat diabetic complications can further be segmented into antihypertensives, lipid-lowering drugs (for both cholesterol and triglycerides), antiarrhythmatic drugs and drugs to treat peripheral vascular diseases. Each segment of the diabetes-care market, therefore, has different dynamics and different emphases, despite the focus on a single condition (hyperglycemia) and its complications.

Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.

Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.

...Show More ...Show Less


Filter your search

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Diabetes Industry Research & Market Reports

  • Global Diabetes Drugs Market Forecast 2018-2026

    ... forecast years of 2018-2026, the global diabetes drugs market is expected to evolve further at a 6.49% CAGR. MARKET INSIGHTS The global diabetes drugs market is segmented on the basis of product class and diabetes ... Read More

  • Global Human Microbiome Market Forecast 2018-2022

    ... is anticipated to exhibit a CAGR of 22.41% between 2022-2026. MARKET INSIGHTS The global human microbiome market is segmented on the basis of products, applications, and diseases. The product segment is categorized into Foods, Probiotics, ... Read More

  • Asia Pacific Diabetes Drugs Market Forecast 2018-2026

    ... expected to exhibit the fastest CAGR of 10.81% over the forecast period of 2018-2026. MARKET INSIGHTS Several vendors are focusing on strategic collaborations with domestic distribution partners and suppliers to enhance their distribution and sales ... Read More

  • Europe Diabetes Drugs Market Forecast 2018-2026

    ... diabetes drugs. MARKET INSIGHTS An increase in life-expectancy and growing prevalence of diabetes in the population are factors driving growth in the European diabetes drug market. The development of new formulations and increasing research and ... Read More

  • North America Diabetes Drugs Market Forecast 2018-2026

    ... a CAGR of 4.97% over the forecast years of 2018-2026 MARKET INSIGHTS In North America, the US market holds the maximum share in the use of diabetes drugs. Growing diabetic population is responsible for driving ... Read More

  • North America Insulin Therapeutics Market - Segmented by Product Type, Drug Type, Disease Indication, and Geography - Growth, Trends, and Forecast (2018 - 2023)

    ... a CAGR of 8.0% during the forecast period, 2018 to 2023. The United States dominates the market, due to growing prevalence of diabetes and obesity in the country Growing Diabetes Prevalence in North America Diabetes ... Read More

  • Global Insulin Resistance Cell Model Market Research Report 2018

    ... major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Insulin Resistance ... Read More

  • Global Diabetic Peripheral Neuropathy Market Research Report 2018

    ... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Diabetic Peripheral Neuropathy basics: ... Read More

  • Global Diabetic Macular Edema Market Research Report 2018

    ... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Diabetic Macular Edema basics: ... Read More

  • Global Insulin Resistance Erythrocyte Market Research Report 2018

    ... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Insulin Resistance Erythrocyte basics: ... Read More

  • Global Diabetic Retinopathy Treatment Market Research Report 2018

    ... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Diabetic Retinopathy Treatment basics: ... Read More

  • Global and Chinese Insulin Needle Industry, 2018 Market Research Report

    ... market. The report provides key statistics on the market status of the Insulin Needle manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides ... Read More

  • Insulin Delivery - Medical Devices Pipeline Assessment, 2018

    ... provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical ... Read More

  • The U.S. Health Coaching Market

    ... bad lifestyle habits and to manage chronic conditions such as diabetes. You are most likely to find a health coach in private practice, at a doctor’s office, or via a corporate wellness program. Large self-insured ... Read More

  • Insulin Pumps - Medical Devices Pipeline Assessment, 2018

    ... provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical ... Read More

  • Russia Diabetes Market Report: 2018 - 2023

    ... future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Russia. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook ... Read More

  • United States Diabetes Market Report: 2018 - 2023

    ... US, it represented the world’s third largest diabetes patient pool in 2017. The prevailing cases of diabetes are largely due to rising obesity levels and an increasing aging population. It has been found in the ... Read More

  • Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

    ... Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable ... Read More

  • United Kingdom Diabetes Market Report: 2018 - 2023

    ... current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in UK. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and ... Read More

  • Brazil Diabetes Market Report: 2018 - 2023

    ... in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Brazil. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the ... Read More

  • Italy Diabetes Market Report: 2018-2023

    ... prevalence, demographical breakup, diagnosis and treatment of diabetes in Italy. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Italy diabetes ... Read More

  • China Diabetes Market Report: 2018-2023

    ... percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world. The rise of diabetes in China can be attributed ... Read More

  • Canada Diabetes Market Report: 2018-2023

    ... prevalence, demographical breakup, diagnosis and treatment of diabetes in Canada. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Canada diabetes ... Read More

  • Japan Diabetes Market Report: 2018-2023

    ... prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japan diabetes ... Read More

  • Germany Diabetes Market Report: 2018 - 2023

    ... future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Germany. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook ... Read More

< prev 1 3 4 5 6 7 8 9 10